- Home
- GTEC vs DRRX Comparison
GTEC vs DRRX Comparison
Compare GTEC & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- DRRX
- Stock Information
- Founded
- GTEC 2006
- DRRX 1998
- Country
- GTEC United States
- DRRX United States
- Employees
- GTEC N/A
- DRRX N/A
- Industry
- GTEC Industrial Machinery/Components
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- GTEC Industrials
- DRRX Health Care
- Exchange
- GTEC Nasdaq
- DRRX Nasdaq
- Market Cap
- GTEC 18.2M
- DRRX 24.8M
- IPO Year
- GTEC N/A
- DRRX 2000
- Fundamental
- Price
- GTEC $1.26
- DRRX $0.81
- Analyst Decision
- GTEC
- DRRX Buy
- Analyst Count
- GTEC 0
- DRRX 2
- Target Price
- GTEC N/A
- DRRX $5.00
- AVG Volume (30 Days)
- GTEC 125.2K
- DRRX 34.1K
- Earning Date
- GTEC 04-15-2025
- DRRX 03-26-2025
- Dividend Yield
- GTEC N/A
- DRRX N/A
- EPS Growth
- GTEC N/A
- DRRX N/A
- EPS
- GTEC N/A
- DRRX N/A
- Revenue
- GTEC $87,352,614.00
- DRRX $8,594,000.00
- Revenue This Year
- GTEC N/A
- DRRX $54.32
- Revenue Next Year
- GTEC $1.70
- DRRX N/A
- P/E Ratio
- GTEC N/A
- DRRX N/A
- Revenue Growth
- GTEC 0.76
- DRRX N/A
- 52 Week Low
- GTEC $1.25
- DRRX $0.70
- 52 Week High
- GTEC $2.94
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- GTEC 28.39
- DRRX 53.18
- Support Level
- GTEC $1.28
- DRRX $0.71
- Resistance Level
- GTEC $1.38
- DRRX $0.87
- Average True Range (ATR)
- GTEC 0.15
- DRRX 0.05
- MACD
- GTEC -0.02
- DRRX 0.01
- Stochastic Oscillator
- GTEC 1.59
- DRRX 61.88
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .